Anaerobe

Anaerobic clinical microbiology remains a challenge due to specialist culture requirements, coupled with the increase in and spread of antimicrobial resistance. The normal human microbiota is primarily composed of anaerobic bacteria, and is now recognised as a source of life-threatening anaerobic infection. More recent metataxonomic and metagenomic sequencing has extended interest in the potential role of the microbiota in a plethora of other aspects of human health, from obesity to mental health. In addition, the successful use of faecal microbiota transplants for the treatment of clostridial infection raises potential unchartered long-term consequences and possibilities.
In conjunction with Anaerobe 2019 and Anaerobe 2021, this collection will provide scientific insights into the future impact of anaerobic bacteria in human health and disease, addressing the implications of recent microbiota studies as well as the continued threat of emerging and re-emerging anaerobic infection.
This collection is open for submissions – please submit your article here, stating that your manuscript is part of the Anaerobe collection.